197 related articles for article (PubMed ID: 12203035)
1. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
Costa AM; Lemos-Marini SH; Baptista MT; Morcillo AM; Maciel-Guerra AT; Guerra G
J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
[TBL] [Abstract][Full Text] [Related]
2. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
3. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients.
Carrascosa A; Gussinyé M; Terradas P; Yeste D; Audí L; Vicens-Calvet E
J Bone Miner Res; 2000 Oct; 15(10):2005-10. PubMed ID: 11028454
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
Strandberg S; Nordström P; Lorentzon R; Lorentzon M
J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
[TBL] [Abstract][Full Text] [Related]
6. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry.
Högler W; Briody J; Moore B; Garnett S; Lu PW; Cowell CT
J Clin Endocrinol Metab; 2004 Jan; 89(1):193-9. PubMed ID: 14715849
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome.
El-Mansoury M; Barrenäs ML; Bryman I; Hanson C; Larsson C; Wilhelmsen L; Landin-Wilhelmsen K
Clin Endocrinol (Oxf); 2007 May; 66(5):744-51. PubMed ID: 17381484
[TBL] [Abstract][Full Text] [Related]
8. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome.
Han TS; Cadge B; Conway GS
Clin Endocrinol (Oxf); 2006 Nov; 65(5):643-7. PubMed ID: 17054467
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and correlation factor analysis in normal Taiwanese children.
Shu SG
Acta Paediatr Taiwan; 2007; 48(6):323-7. PubMed ID: 18437966
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
Abeş M; Sarihan H; Madenci E
J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome in Turner syndrome.
Parvin M; Roche E; Costigan C; Hoey HM
Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
[TBL] [Abstract][Full Text] [Related]
16. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
17. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
18. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
19. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome.
Bannink EM; Raat H; Mulder PG; de Muinck Keizer-Schrama SM
J Pediatr; 2006 Jan; 148(1):95-101. PubMed ID: 16423606
[TBL] [Abstract][Full Text] [Related]
20. The relationship between lean body mass and bone mineral content in paediatric health and disease.
Crabtree NJ; Kibirige MS; Fordham JN; Banks LM; Muntoni F; Chinn D; Boivin CM; Shaw NJ
Bone; 2004 Oct; 35(4):965-72. PubMed ID: 15454104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
